{
  "ticker": "BPH",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973369",
  "id": "02973369",
  "pages": 8,
  "price_sensitive": true,
  "date": "20250728",
  "time": "1515",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250728/pdf/06m6trxy317y8c.pdf",
  "summary": "Here\u2019s the concise extraction of material information from the BPH Energy Ltd June 2025 Quarterly Report (Appendix 4C):  \n\n### **BPH Energy Ltd \u2013 June 2025 Quarterly Report Highlights**  \n\n#### **Key Operational Updates**  \n- **Advent Energy (35.8% stake) \u2013 PEP-11 Permit**:  \n  - Federal Court hearing scheduled for **16-17 September 2025** regarding judicial review of permit refusal.  \n  - PEP-11 remains in force; JV compliant with regulatory obligations.  \n\n- **Cortical Dynamics (16.4% stake) \u2013 BARM 2.0 AI Medical Device**:  \n  - **Technical completion expected soon**, with **upcoming clinical trials** in the USA and Netherlands.  \n  - Regulatory engagement: Showcased at **Australia Regulatory Device Summit 2025** (FDA, TGA attendees).  \n  - Selected for **Medtech on the Hill** event (Parliament House, August 2025).  \n\n- **Clean Hydrogen Technologies (16.2% stake)**:  \n  - Pilot plant in India producing **turquoise hydrogen and carbon nanotubes** (no CO\u2082 emissions).  \n  - **US$2.5M funding needed** to launch production facilities in India/USA; design approvals nearing completion.  \n\n#### **Financial Summary (Appendix 4C)**  \n- **Cash Balance (EOQ)**: **A$4.065M** (vs. A$4.829M previous quarter).  \n- **Quarterly Cash Outflows**:  \n  - **Operating**: **A$(67K)** (net loss).  \n  - **Investing**: **A$(697K)** (loans to Advent: A$237K, Cortical: A$460K).  \n- **Funding Runway**: **~60.7 quarters** (based on current cash and burn rate).  \n\n#### **Material Payments to Related Parties**  \n- **A$48K**: Director remuneration (A$19K) + fees to Grandbridge Ltd (A$28K).  \n- **A$697K**: Loans to investees (Advent + Cortical).  \n\n**No capital raising or material corporate actions announced.**  \n\n*Note: Focus on catalysts (court hearing, BARM 2.0 trials, CHT funding) and liquidity position (cash runway, investee funding needs).*",
  "usage": {
    "prompt_tokens": 4433,
    "completion_tokens": 493,
    "total_tokens": 4926,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-28T06:02:55.881613"
}